Asima Health is revolutionizing cancer care with an innovative blood test that delivers tumor-naïve, pan-cancer results in just 6-8 hours at 10x lower cost per test. Unlike traditional liquid biopsy tests that rely on third-party centralized labs, our innovative benchtop technology is specifically designed for hospital labs. By enabling in-house testing with streamlined workflows requiring less than an hour of hands-on time, hospitals can retain revenue, foster collaboration between oncologists and pathologists, and improve patient outcomes—all while significantly lowering costs for payers.